Anamol Laboratories Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 16-11-2024
- Paid Up Capital ₹ 3.00 M
as on 16-11-2024
- Company Age 26 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.36 M
as on 16-11-2024
- Satisfied Charges ₹ 2.87 M
as on 16-11-2024
- Revenue -89.09%
(FY 2023)
- Profit -149.93%
(FY 2023)
- Ebitda -150.82%
(FY 2023)
- Net Worth -27.62%
(FY 2023)
- Total Assets -11.49%
(FY 2023)
About Anamol Laboratories
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹5.36 M. The company has closed loans amounting to ₹2.87 M, as per Ministry of Corporate Affairs (MCA) records.
Mahendra Dashora, Uma Dashora, and Priyank Dashora serve as directors at the Company.
- CIN/LLPIN
U85195MH1998PTC154272
- Company No.
154272
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jan 1998
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Anamol Laboratories Private Limited offer?
Anamol Laboratories Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Rapid Test Kit, Medical Surgery & Treatment Centres, Medical Treatment Services, Chemical Reagents & Catalysts, Organic Acid, Flavours & Aromatics, Food Preservative, Pharma Ingredients & Raw Materials, Pharmaceutical Excipients.
Who are the key members and board of directors at Anamol Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahendra Dashora  | Director | 30-Nov-2021 | Current |
| Uma Dashora | Director | 30-Nov-2021 | Current |
| Priyank Dashora | Director | 01-Feb-2019 | Current |
Financial Performance of Anamol Laboratories.
Anamol Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 89.09% decrease. The company also saw a substantial fall in profitability, with a 149.93% decrease in profit. The company's net worth observed a substantial decline by a decrease of 27.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anamol Laboratories?
In 2023, Anamol Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Feb 2023 | ₹1.90 M | Open |
Bank Of India Creation Date: 14 Oct 2022 | ₹0.97 M | Open |
State Bank Of India Creation Date: 12 Jul 2021 | ₹2.49 M | Open |
How Many Employees Work at Anamol Laboratories?
Anamol Laboratories has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anamol Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anamol Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
